Recros Medica, Inc., a San Diego, CA-based development stage medical aesthetic device company focused on reducing skin laxity and focal contouring, closed a $9M financing.
Backers included Longwood Fund. The company is also strengthening its Board of Directors with the additions of:
– Christoph Westphal, MD, PhD, a co-founder and Partner of the Longwood Fund, and
– Mark Kerslake, Principal of the Province Group, a Newport Beach, CA real estate development and investment company active in the acquisition, entitlement, management, and disposition of residential and mixed-use real estate projects in multiple states.
Recros Medica intends to use the funds to expand its technology platforms in the aesthetics market.
Co-founded in 2014 by Dr. Edward Knowlton, and David F. Hale, Chairman of the Board, and led by Tom Albright, President and CEO, Recros Medica is developing a new medical aesthetic technology platform (Rotational Fractional Resection) with multiple clinical applications for medical aesthetic physicians. The primary opportunity for this platform is the development of clinical applications for use by Dermatologists, Plastic Surgeons & other aesthetic physicians that treat skin laxity and focal aesthetic contour deformities in the submentum (under the chin), upper arms, knees and other areas where visible scarring limits the use of traditional plastic surgery.